Literature DB >> 25434362

The molecular mechanisms and therapeutic potential of microRNA-7 in cancer.

Dian-Na Gu1, Qian Huang, Ling Tian.   

Abstract

INTRODUCTION: Increasing evidence supports that microRNAs (miRNAs) play crucial roles in cancer through post-transcriptional gene silencing of their target genes, therefore, more and more effort has been devoted to develop miRNA-targeting therapeutics in cancer. MicroRNA-7 (miR-7) has been characterized as a potential tumor suppressor and regulates diverse fundamental biological processes of cancer cells including initiation, proliferation, migration, invasion, survival and death by targeting a number of oncogenic signaling pathways. AREAS COVERED: This review examines evidence of the biological responses of miR-7 in cancer, with an emphasis on its regulation of the vital oncogenic signaling pathways. It also discusses the rationale, strategies and challenges of miR-7 as a potential therapeutic target for cancer. EXPERT OPINION: With the increasing understanding of molecular mechanisms of miR-7-mediated regulatory networks and the advancement of miRNA-based therapeutics, targeting miR-7 may be a potential and promising strategy for cancer therapy.

Entities:  

Keywords:  cancer cell signaling; microRNA; microRNA-7; microRNA-based therapeutics; post-transcriptional regulation

Mesh:

Substances:

Year:  2014        PMID: 25434362     DOI: 10.1517/14728222.2014.988708

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  17 in total

1.  Loss of microRNA-7a2 induces hypogonadotropic hypogonadism and infertility.

Authors:  Kashan Ahmed; Mary P LaPierre; Emanuel Gasser; Rémy Denzler; Yinjie Yang; Thomas Rülicke; Jukka Kero; Mathieu Latreille; Markus Stoffel
Journal:  J Clin Invest       Date:  2017-02-20       Impact factor: 14.808

2.  Circular RNA ciRS-7-A Promising Prognostic Biomarker and a Potential Therapeutic Target in Colorectal Cancer.

Authors:  Wenhao Weng; Qing Wei; Shusuke Toden; Kazuhiro Yoshida; Takeshi Nagasaka; Toshiyoshi Fujiwara; Sanjun Cai; Huanlong Qin; Yanlei Ma; Ajay Goel
Journal:  Clin Cancer Res       Date:  2017-02-07       Impact factor: 12.531

3.  Verification of candidate microRNA markers for parathyroid carcinoma.

Authors:  Ya Hu; Xiang Zhang; Ming Cui; Zhe Su; Mengyi Wang; Quan Liao; Yupei Zhao
Journal:  Endocrine       Date:  2018-02-16       Impact factor: 3.633

4.  MicroRNA-7 inhibits the stemness of prostate cancer stem-like cells and tumorigenesis by repressing KLF4/PI3K/Akt/p21 pathway.

Authors:  Yun-Li Chang; Pei-Jie Zhou; Lianzi Wei; Wang Li; Zhongzhong Ji; Yu-Xiang Fang; Wei-Qiang Gao
Journal:  Oncotarget       Date:  2015-09-15

Review 5.  Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review).

Authors:  Roberto Gambari; Eleonora Brognara; Demetrios A Spandidos; Enrica Fabbri
Journal:  Int J Oncol       Date:  2016-05-04       Impact factor: 5.650

6.  Potential role of miR-139-5p in cancer diagnosis, prognosis and therapy.

Authors:  Ling-Li Huang; Ling-Wei Huang; Lei Wang; Ben-Ding Tong; Qing Wei; Xuan-Sheng Ding
Journal:  Oncol Lett       Date:  2017-06-08       Impact factor: 2.967

7.  Oleic Acid Induces MiR-7 Processing through Remodeling of Pri-MiR-7/Protein Complex.

Authors:  Santosh Kumar; Angela Downie Ruiz Velasco; Gracjan Michlewski
Journal:  J Mol Biol       Date:  2017-05-05       Impact factor: 5.469

Review 8.  The Role of MicroRNAs in the Regulation of K(+) Channels in Epithelial Tissue.

Authors:  Elliot Pilmore; Kirk L Hamilton
Journal:  Front Physiol       Date:  2015-12-01       Impact factor: 4.566

Review 9.  Clinical Potential of microRNA-7 in Cancer.

Authors:  Jessica L Horsham; Felicity C Kalinowski; Michael R Epis; Clarissa Ganda; Rikki A M Brown; Peter J Leedman
Journal:  J Clin Med       Date:  2015-08-25       Impact factor: 4.241

10.  CircHIPK3 promotes colorectal cancer growth and metastasis by sponging miR-7.

Authors:  Kaixuan Zeng; Xiaoxiang Chen; Mu Xu; Xiangxiang Liu; Xiuxiu Hu; Tao Xu; Huiling Sun; Yuqin Pan; Bangshun He; Shukui Wang
Journal:  Cell Death Dis       Date:  2018-04-01       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.